Gladius Capital Management »

Iradimed shares owned by Gladius Capital Management

Quarter-by-quarter ownership of Iradimed (IRMD) shares owned by Gladius Capital Management from 13F filings

Historical chart of Gladius Capital Management investment in Iradimed

Tip: Access up to 7 years of quarterly data

All positions including Iradimed held by Gladius Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iradimed by Gladius Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $34k 717 47.47
2023-09-30 $36k 809 44.37

More positions owned by Gladius Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Put Put Option
Apple Put Put Option
Microsoft Corp Put Put Option
Ishares Gold Tr Ishares New (IAU)
Apple Call Call Option
Advanced Micro Devices Put Put Option
Alphabet Put Put Option
Micron Technology Put Put Option
Nvidia Corporation Put Put Option
Microsoft Corp Call Call Option
Amazon Call Call Option
Amazon Put Put Option
Broadcom Put Put Option
Meta Platforms Put Put Option

View all positions for Gladius Capital Management

Top funds holding Iradimed

Soleus Capital Management
Vanguard Group
Copeland Capital Management
Bares Capital Management
Russell Investments
Dimensional Fund Advisors
Resource Consulting Group
Millennium Management
Hillsdale Investment Management
Rice Hall James & Associates
Goldman Sachs Group
Bank of New York Mellon
Thomas Stevens, CFA"
Bridge City Capital
Henderson Group

View all funds holding Iradimed